相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D
Pornpattana Vichitvejpaisal et al.
OPHTHALMOLOGY (2019)
Prognostic factors for metastasis in cutaneous melanoma
Ana Carolina Figueiredo Pereira Cherobin et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2018)
Targeting invasive properties of melanoma cells
Imanol Arozarena et al.
FEBS JOURNAL (2017)
Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells
Yusuf A. Haggag et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor
Sean Caenepeel et al.
Oncotarget (2017)
Ran GTPase promotes cancer progression via Met receptor-mediated downstream signaling
Hiu-Fung Yuen et al.
ONCOTARGET (2016)
Ran signaling in melanoma: Implications for the development of alternative therapeutic strategies
Emilia Caputo et al.
CANCER LETTERS (2015)
The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma
Kate Lynn J. Bill et al.
LABORATORY INVESTIGATION (2015)
Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4
Lin Deng et al.
CANCER BIOLOGY & THERAPY (2014)
Ran GTPase protein promotes human pancreatic cancer proliferation by deregulating the expression of Survivin and cell cycle proteins
Lin Deng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
High Ran level is correlated with poor prognosis in patients with colorectal cancer
Hongwei Fan et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
Mitotic rate and subcutaneous involvement are prognostic factors for survival after recurrence in patients with only locoregional skin metastasis as the first site of recurrence from cutaneous melanoma
F. Messeguer et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
Hiu-Fung Yuen et al.
CLINICAL CANCER RESEARCH (2012)
RAN GTPase as a Target for Cancer Therapy: Ran Binding Proteins
K. J. Doherty et al.
CURRENT MOLECULAR MEDICINE (2011)
Genetic and morphologic features for melanoma classification
Sigrid M. C. Broekaert et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
Somaia E. Elsheikh et al.
CANCER RESEARCH (2009)
Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
S. E. Elsheikh et al.
BRITISH JOURNAL OF CANCER (2008)
RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin
V. V. Kurisetty et al.
ONCOGENE (2008)
Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: A case-controlled study
Leonardo Sartore et al.
International Journal of Surgery (2008)
Improving melanoma classification by integrating genetic and morphologic features
Amaya Viros et al.
PLOS MEDICINE (2008)
Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients
K Azuma et al.
CLINICAL CANCER RESEARCH (2004)
Ran in the spindle checkpoint: a new function for a versatile GTPase
HY Li et al.
TRENDS IN CELL BIOLOGY (2003)
分享论文
